Mums v Big Pharma: The Sodium Valproate Scandal Exposed 2026

The sodium valproate scandal, exposed by two ordinary mothers, is a chilling example of corporate and regulatory failure. Their campaign, now the subject of the documentary Mums v Big Pharma, reveals how a common epilepsy drug caused devastating birth defects and developmental delays in thousands of children.

Janet Williams, one of the mothers, had two sons with developmental delays. For years, doctors told her nothing was wrong. Then in 2009, a specialist casually mentioned that their condition was likely caused by her epilepsy medication, Epilim—the brand name for sodium valproate.

The Origins of Sodium Valproate

Sodium valproate was discovered in 1962 as an effective anti-seizure drug and later used to treat bipolar disorder. By the 1990s, when Williams was having her children, it was widely prescribed to women of childbearing age. However, the drug's risks during pregnancy were known to the manufacturer, Sanofi, but not adequately communicated to patients or doctors.

The documentary Mums v Big Pharma traces how Williams and another mother, Emma Murphy, began to suspect a link between their children's disabilities and the drug. Their campaign, started 17 years ago, faced numerous obstacles, including legal threats and regulatory inertia.

The Human Cost of Sodium Valproate

Children exposed to sodium valproate in the womb can suffer from physical abnormalities, autism, and learning difficulties. The documentary features heart-wrenching testimonies from families affected by the drug. Many mothers were never warned of the risks, and some were even advised to continue taking the drug during pregnancy.

The scandal highlights a broader issue: how pharmaceutical companies and regulators often downplay risks to protect profits. The mothers' campaign forced the UK's Medicines and Healthcare products Regulatory Agency (MHRA) to issue stronger warnings, but only after years of pressure.

Key Takeaways from the Documentary

• Corporate negligence: Sanofi knew about the risks but failed to warn patients adequately.
• Regulatory failure: The MHRA was slow to act despite mounting evidence.
• Power of grassroots activism: Two mothers without legal or medical training exposed a nationwide scandal.
• Ongoing fight: Many families are still seeking compensation and recognition.
• Need for transparency: The case underscores the importance of informed consent and drug safety monitoring.

Comparing Sodium Valproate Risks

These statistics are staggering, yet for decades they were buried in obscure medical literature. The mothers' campaign brought them into the public eye.

The Role of Big Pharma

Sanofi, the manufacturer of Epilim, has consistently denied wrongdoing, claiming it followed regulatory guidelines. However, internal documents revealed that the company was aware of the risks as early as the 1980s. The documentary suggests that profit motives led to a deliberate downplaying of the dangers.

This pattern is not unique to sodium valproate. Similar scandals have rocked the pharmaceutical industry, from thalidomide to opioids. The common thread is a lack of accountability and transparency. The background to this story is set out in Unmarried Mothers Forced to Give Up Babies: A Powerful Documentary. A related thread runs through Polymarket HSBC Lloyds Failure Bets Spark UK Regulatory Alarm. Earlier coverage in Celebrity: latest articles shows how the argument developed.

What Needs to Change

The sodium valproate scandal has led to some reforms, including stricter prescribing guidelines and a pregnancy prevention programme. But campaigners argue that more needs to be done, including compensation for affected families and greater independence for regulators. A closer look at the same subject appears in Jensen Huang's Image Shattered: Could He Be Pushed Out at Nvidia. Anyone following the wider picture can start with One in a Million: A Syrian Family's 10-Year Journey to Safety. The same theme surfaces in 1 in 2 Review: A Compassionate Plea on Young Bowel Cancer, which takes a different angle.

The documentary Mums v Big Pharma is a powerful reminder that ordinary people can hold powerful institutions to account. It also serves as a warning about the dangers of unchecked corporate power. Context on how this played out before sits in Amazon Engineer Used ChatGPT to Quit Epilepsy Meds and Died. A companion piece, Nvidia Board Urged to Plan Succession Amid Spy Scandal, approaches the same subject from another angle.

FAQ